FDA Adverse Event Injury Summary report: N

INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT

MDR report key: 22029068 · Received May 15, 2025

Report

Report Number
9617229-2025-07995
Event Type
Injury
Date Received
May 15, 2025
Date of Event
January 1, 2024
Report Date
July 2, 2025
Manufacturer
ALLERGAN (COSTA RICA)
Product Code
FTR
UDI-DI
5060191607636
PMA / PMN Number
P020056
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

DEVICE EVALUATION: THE DEVICE RELATED TO THE REPORTED EVENTS OF RUPTURE WAS RECEIVED ON MAY 20, 2025, WITH LOT NUMBER 3200798. BASED ON THE PRODUCT ANALYSIS PERFORMED, THE ASSESSMENTS OF THE COMPLAINT CODES ARE: RUPTURE: OBSERVED AN OPENING ASSESSED AS AN UNIDENTIFIED (TEAR) OPENING. NO ADDITIONAL OBSERVATIONS PERFORMED ON THE DEVICE. NO FURTHER ACTIONS ARE REQUIRED. ADDITIONAL, CHANGED, AND/OR CORRECTED DATA: A6, D9, H3, H6.

Additional Manufacturer Narrative · 0

A REVIEW OF THE DEVICE HISTORY RECORD HAS BEEN COMPLETED. NO DEVIATIONS OR NON-CONFORMANCES NOTED. FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN/WILL BE REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. THE REASON(S) FOR REOPERATION IS/ARE: RUPTURE. CLARIFICATION TO PARTIAL B3 IMPLANT DATE: 2024 WAS PROVIDED. CONTINUED E1 PHONE NUMBER: (B)(6).

Description of Event or Problem · 0

HEALTHCARE PROVIDER REPORTED A RIGHT SIDE RUPTURE. THE DEVICE HAS BEEN EXPLANTED AND REPLACED WITH ANOTHER MANUFACTURERS DEVICE.

Description of Event or Problem · 0

HEALTHCARE PROVIDER REPORTED A RIGHT SIDE RUPTURE. THE DEVICE HAS BEEN EXPLANTED AND REPLACED WITH ANOTHER MANUFACTURERS DEVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2011137 INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED FTR ALLERGAN (COSTA RICA) 3200798 5060191607636

Patients

Seq Age Sex Outcome Treatment
1 39 YR Female Required Intervention